Oncology
Oncology Diagnostics entails the use of molecular and protein based assays to detect and monitor the development and presence of benign and cancerous tumours. Cancers are the second leading cause of deaths worldwide. Cancers accounted for 17% of deaths and 18.6 million people are living with cancers globally as of 2020. The leading types of cancers are Breast, Lungs, Colorectal, Prostate, Stomach, Liver and Cervical cancer. Many Nigerians are living with cancer without them knowing.
With the use of our state of the art molecular genetics and protein assay techniques we diagnose and provide genetic profile for different cancers; enabling physicians better understand patients’ condition and administer personalised medicine which improves patients chances of survival.
Our refined diagnostics approach can also detect people who have a high likelihood of developing cancers even before they develop the disease. Below are some of the Oncology tests available at Biologix Laboratories:
EGFR Mutation Test
PIK3CA Mutation Test
BRAF Mutation Test
NRAS Mutation Test
KRAS Mutation Test
ALK Rearrangement Test
MET Mutation Test
RET Mutation Test
ROS-1 Fusion Test
NTRK 1/2/3 Fusion Test
Lung Cancer Panel Test
PD-1 Test
PDL-1 Test
Homologous Recombination Repair (HRR) alterations Test
ERBB2 (HER2) amplification Test
BRCA 1 & 2 Mutations Test
PSA Test
CA- 125 (Cancer Antigen-125) Test
CA- 19.9 (Cancer Antigen 19.9) Test
CA- 15.3 (Cancer Antigen 15.3) Test
